searchIrbesartanSystematic (IUPAC) name2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-oneIdentifiersCAS number 138402-11-6ATC code C09CA04PubChem 3749DrugBank APRD00413Chemical avapro and alzheimer C25H28N6OMol. mass 428.53SMILES eMolecules & PubChemPharmacokinetic dataBioavailability.

Karvezide, Avalide and Avapro HCT.[edit] References^ Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I; Collaborative Study avapro and alzheimer (2001). "Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with avapro and alzheimer due to type 2 diabetes,[1] hypertension and microalbuminuria (>30 mg/24 avapro and alzheimer or proteinuria (>900 mg/24 hours).[2][edit] Combination with diureticIrbesartan is also available in a combination formulation with a avapro and alzheimer dose thiazide diuretic, invariably hydrochlorothiazide, to achieve an additive antihypertensive effect. Irbesartan/hydrochlorothiazide combination preparations are marketed under similar trade names Aprovel, Karvea, and Avapro.Contents avapro and alzheimer Clinical use1.1 Indications1.2 avapro and alzheimer with diureticIrbesartan is also available in a combination formulation with a low dose thiazide diuretic, invariably hydrochlorothiazide, to achieve an avapro and alzheimer antihypertensive effect.

J Med 345 (12): 851-60. PMID 11565517.^ Rossi S, editor. Australian Medicines Handbook 2006. Adelaide: Australian.